CCN2 and Peritoneal Fibrosis: As CCN2 appears an attractive target for antifibrotic therapy, prospective, longitudinal studies are needed to determine whether the dialysate CCN2 concentration or appearance rate combined with peritoneal transport studies can predict the development of peritoneal fibrosis and sclerosis.